Karl Agger
Impact in
- Molecular Biology top 2%
- Epigenetics and DNA Methylation
- Genomics and Chromatin Dynamics
- Cancer-related gene regulation
- Pluripotent Stem Cells Research
- Chromatin Remodeling and Cancer
- Histone Deacetylase Inhibitors Research
- Developmental Biology and Gene Regulation
- Aging top 10%
Papers in
-
- Epigenetics and DNA Methylation 14
- Pluripotent Stem Cells Research 3
- Genomics and Chromatin Dynamics 2
-
- Acute Myeloid Leukemia Research 4
- Hematopoietic Stem Cell Transplantation 2
- Co-authors
- Kristian Helin (18 shared papers)Paul A. Cloos (6 shared papers)Juri Rappsilber (3 shared papers)Jesper Frank Christensen (4 shared papers)Diego Pasini (3 shared papers)Anna Elisabetta Salcini (2 shared papers)Jonas Westergaard Højfeldt (1 shared paper)Klaus H. Hansen (2 shared papers)
- Journals
- Nature Communications (3 papers)Blood (2 papers)Nature (2 papers)Cell Death and Disease (1 paper)The EMBO Journal (1 paper)
- Partner nations
- DenmarkUnited StatesUnited Kingdom
In The Last Decade
Karl Agger
20 papers receiving 3.4k citations
Karl Agger's Hit Papers
Peers
Comparison fields: 5 of 81
- Molecular Biology 2.5k
- Aging 26
- Developmental Neuroscience 43
- Genetics 109
- Hematology 156
Countries citing papers authored by Karl Agger
This map shows the geographic impact of Karl Agger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl Agger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl Agger more than expected).
Fields of papers citing papers by Karl Agger
This network shows the impact of papers produced by Karl Agger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl Agger. The network helps show where Karl Agger may publish in the future.
Co-authors
The 25 scholars most cited alongside Karl Agger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development Hit paper breakdown → | 2007 | 1087 |
| 2 | 2006 | 626 | |
| 3 | 2007 | 446 | |
| 4 | 2013 | 392 | |
| 5 | 2016 | 203 | |
| 6 | 2008 | 183 | |
| 7 | 2004 | 96 | |
| 8 | 2016 | 92 | |
| 9 | 2011 | 86 | |
| 10 | 2014 | 67 | |
| 11 | 2019 | 56 | |
| 12 | 2004 | 35 | |
| 13 | 2021 | 27 | |
| 14 | 2019 | 25 | |
| 15 | 2008 | 14 | |
| 16 | 2024 | 13 | |
| 17 | 2024 | 8 | |
| 18 | 2023 | 6 | |
| 19 | 2025 | 2 | |
| 20 | 2024 | 1 |
About Karl Agger
Karl Agger is a scholar working on Molecular Biology, Hematology, Oncology, Biochemistry and Genetics, having authored 20 papers that have together received 3.5k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (14 papers), Acute Myeloid Leukemia Research (4 papers), Pluripotent Stem Cells Research (3 papers), Genomics and Chromatin Dynamics (2 papers), Cancer-related Molecular Pathways (2 papers), Hematopoietic Stem Cell Transplantation (2 papers), Testicular diseases and treatments (1 paper) and Pancreatic function and diabetes (1 paper). The work is most often cited by research in Molecular Biology (2.5k citations), Aging (26 citations), Developmental Neuroscience (43 citations), Genetics (109 citations) and Hematology (156 citations). Karl Agger has collaborated with scholars based in Denmark, United States and United Kingdom. Frequent co-authors include Kristian Helin, Paul A. Cloos, Juri Rappsilber, Jesper Frank Christensen, Diego Pasini, Anna Elisabetta Salcini, Jonas Westergaard Højfeldt, Klaus H. Hansen, Eli Canaani and Irina Issaeva. Their work appears in journals such as Nature Communications, Blood, Nature, Cell Death and Disease and The EMBO Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.